RECURRENT HEAD AND NECK CARCINOMA
Clinical trials for RECURRENT HEAD AND NECK CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT HEAD AND NECK CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT HEAD AND NECK CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo targets tough cancers in early trial
Disease control CompletedThis study tested a combination of two drugs—sEphB4-HSA and pembrolizumab—in 42 people with advanced non-small cell lung cancer or head & neck cancer that had spread or returned. The goal was to see if the combo could shrink tumors better than standard treatments. Participants ha…
Matched conditions: RECURRENT HEAD AND NECK CARCINOMA
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 26, 2026 07:56 UTC
-
Radioactive seeds implanted during surgery show promise for recurrent head and neck cancer
Disease control CompletedThis study tested a new approach for people whose head and neck cancer has come back. During surgery to remove the tumor, doctors placed tiny radioactive seeds (Cesium-131) directly into the area to kill any remaining cancer cells. The goal was to see if this internal radiation c…
Matched conditions: RECURRENT HEAD AND NECK CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
Early study explores Erlotinib's effect on head and neck tumors
Knowledge-focused CompletedThis early-phase study tested two doses of the drug erlotinib given before surgery to 48 people with head and neck cancer. The goal was to see how the drug affects certain markers in tumor tissue, not to cure the disease. The study was completed and focused on measuring biologica…
Matched conditions: RECURRENT HEAD AND NECK CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 07:50 UTC